Advanced search
Publication Cover
Leukemia & Lymphoma Volume 13, 1994 - Issue 5-6
Submit an article Journal homepage
16
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma

Meletios A. Dimopoulos The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Donna M. Weber The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Jeane Hester The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Kay Delasalle The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
,
Richard Champlin The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
&
Raymond Alexanian The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Pages 479-484 | Received 17 Jul 1993, Published online: 01 Jul 2009

References

  • Barlogie B., Smith L., Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N. Engl. J. Med. 1989; 310: 1353–1356
  • Alexanian R., Barlogie B., Dixon D. High dose glucocorticoid treatment of resistant myeloma. Ann. Intern. Med. 1986; 105: 8–11
  • Gharton G., Tura S., Ljungman OP. Allogeneic bone marrow transplantation in multiple myeloma. N. Engl. J. Med. 1991; 325: 507–511
  • Jagannath S., Barlogie B., Dicke K., Alexanian R., Za-Gars G, Cheson B., Lemaistre F., Smallwood L., Pruitt K., Dixon D. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860–1866
  • Fermand J., Levy Y., Gerota I., Benbunan M., Cosset J. M., Castaignes S., Seligmann M., Brouet J. C. Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cell autologous graft. Blood 1989; 73: 20–23
  • Selby P., McElwain T., Nandi A. C., Perren T. J., Powles R. L., Tillyet C. R., Osborne R. J., Slevin M. L., Mal-Pas J. S. Multiple myeloma treated with high dose intravenous melphalan. Br. J. Haematol. 1987; 66: 55–62
  • Barlogie B., Alexanian R., Smallwood L., Cheson B., Dixon D., Dicke K., Cabanillas F. Prognostic factors with high dose melphalan for refractory multiple myeloma. Blood 1988; 72: 215–219
  • Barlogie B., Jagannath S., Dixon D., Cheson B., Small-Wood L, Hendrickson A., Purvis J. D., Bonnem E., Alexanian R. High dose melphalan and granulocyte-macrophage colony-stimulating factors for refractory multiple myeloma. Blood 1990; 76: 677–680
  • Barlogie B., Velasquez W., Alexanian R., Cabanillas F. Etoposide, dexamethasone and cisplatin in vincristine, doxorubicin and dexamethasone-refractory myeloma. J. Clin. Oncol. 1989; 7: 1514–1518
  • Dimopoulos M. A., Alexanian R., Przepiorka D., Hester J., Andersson B., Giralt S., Mehra R., van Besien K., Delasalle K., Reading C., Deisseroth A. B., Champlin R. E. Thiotepa, busulfan and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high risk multiple myeloma. Blood, in press
  • McLaughlin P., Alexanian R. Myeloma protein kinetics following chemotherapy. Blood 1982; 60: 851–855
  • Barlogie B., Alexanian R., Dixon D., Smith L., Small-Wood L., Delasalle K. Prognostic implication of tumor cell DNA and RNA content in multiple myeloma. Blood 1985; 66: 338–341
  • Barlogie B., Smallwood L., Smith T., Alexanian R. High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma. Ann. Intern. Med. 1989; 110: 521–525
  • Chang T., Gulati S., Chou T. C., Colvin M., Clark-Son B. Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors. Cancer Res. 1987; 47: 119–122
  • Chang T., Gulati S., Chou T. C., Vega R., Gandola L., Ezzat Ibrahim S. M., Yopp J., Colvin M., Clarkson B. Synergistic effect of 4-hydroperoxycyclophos-phamide and etoposide on a human promyelocytic leukemia cell line (HL-60). Cancer Res. 1985; 45: 2434–2439
  • Dombernowsky P., Nissen N. I. Combination chemotherapy with 4-demethylepipodophyllotoxin 9 in L1210 leukemia. Eur. J. Cancer 1976; 22: 181–188
  • Brown R. A., Herzig R. H., Wolf S. N., Frei-Lahr D., Pineiro L., Bolwell B. J., Lowder J. N., Hayden E. A., Hande K. R., Herzig G. P. High dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy. Blood 1990; 76: 473–479
  • Jagannath S., Vesole D. H., Glenn L., Crowley J., Barlogie B. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666–1672
  • Gockerman J., Bartolucci A., Nelson M. Phase II evaluation of etoposide in refractory multiple myeloma. Cancer Treat. Rep. 1986; 70: 801–802
  • Gianni A. M., Bregni M., Siena S., Magni M., Di Nicola M., Lombardi F., Tarella C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients. J. Clin. Oncol. 1992; 12: 1955–1962
  • Dimopoulos M., Barlogie B., Smith T., Alexanian R. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma. Ann. Intern. Med. 1991; 115: 931–935

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.